Dr. Mattano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
HARP Pharma Consulting, LLC
184 Masons Island Road
Mystic, CT 06355Phone+1 860-501-1577
Summary
- Pediatric hematologist/oncologist. Clinical researcher. Drug development consultant (www.linkedin/in/lenmattano). Literary and inspirational suspense novelist (www.lenmattano.com).
Education & Training
- University of MichiganFellowship, Pediatric Hematology/Oncology, 1988 - 1991
- University of MichiganResidency, Pediatrics, 1985 - 1988
- University of Michigan Medical SchoolClass of 1985
Certifications & Licensure
- MI State Medical License 1990 - 2027
Clinical Trials
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2005 Apr 11
Publications & Presentations
PubMed
- 353 citationsPAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L. Churchman, Kathryn G. Roberts, Ian Moore, Xin Zhou
Nature Genetics. 2019-02-01 - 133 citationsThe genomic landscape of pediatric acute lymphoblastic leukemia.Samuel W Brady, Kathryn G Roberts, Zhaohui Gu, Lei Shi, Stanley Pounds
Nature Genetics. 2022-09-01 - 91 citationsGenomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.Kathryn G. Roberts, Shalini C. Reshmi, Richard C. Harvey, I-Ming Chen, Kinnari Patel
Blood. 2018-08-23
Authored Content
- Celtic Crossing, A Novel by Len MattanoSeptember 2019
Committees
- Chair, Children's Oncology Group Industry Relations Committee
External Links
- Author websitehttps://www.lenmattano.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: